Sangamo Therapeutics Inc (0R1D)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 19.39M | 36.57M | 84.45M | 102.43M | 118.19M | 110.7M | 111.3M | 176.23M |
| Operating Income | -72.56M | -56.36M | -77.15M | -105.18M | -129.55M | -183.34M | -201.28M | -208.48M |
| Pre Tax Income | -71.67M | -54.57M | -68.89M | -95.42M | -120.78M | -177.99M | -191.85M | -262.9M |
| Net Income | -71.66M | -54.57M | -68.33M | -95.19M | -121M | -178.29M | -192.28M | -257.83M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -1.011 | -0.637 | -0.669 | -0.821 | -0.852 | -1.222 | -1.153 | -1.454 |
| EBIT | -71.67M | -54.57M | -68.89M | -105.18M | -129.55M | -183.34M | -201.28M | -208.48M |
| EBITDA | -71.56M | -54.86M | -74.79M | -101.25M | -123.87M | -173.9M | -189.17M | -103.93M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
